文献速递脑血管病外科神经重症

血清内皮细胞特异性分子1作为实验性蛛网膜下腔出血潜在生物标志物的啮齿动物模型研究

Serum Endocan as a Potential Biomarker in Experimental Subarachnoid Hemorrhage: A Rodent Model Study.
PubMed 文献 · World Neurosurg · 2026-04-07

结果显示SAH组血清内皮细胞特异性分子1(endocan)在6、24、48小时均显著高于假手术组,且48小时endocan水平与海马神经元变性评分呈探索性正相关(ρ=0.753,P=0.031,95%CI [0.112-0.948])。提示endocan可能反映SAH后早期脑损伤中的内皮激活,需更大规模临床前及临床研究验证。

要点

  • SAH后6、24、48小时血清endocan显著升高,且随时间进行性上升。
  • 48小时endocan水平与海马神经元变性评分呈探索性正相关。
  • endocan或可反映SAH后早期脑损伤中的内皮激活,尚需验证。

核心结论

  • 在探索性实验中,SAH后血清endocan随时间升高并与神经元损伤严重程度相关。
  • 初步提示endocan可能反映SAH后早期脑损伤期间的内皮激活,需在更大规模研究验证。

研究设计与样本

  • SAH通过枕大池注射自体血诱导,于基线(0)、6、24、48小时采集血清。
  • 采用酶联免疫吸附试验测定endocan浓度,组织病理学评估海马神经元变性。
  • 统计分析包括独立样本t检验、重复测量方差分析和Spearman相关分析。

主要发现

  • 基线endocan水平两组相当(P=0.655)。
  • SAH组血清endocan在6小时(P=0.023)、24小时(P<0.001)、48小时(P<0.001)均显著高于假手术组。
  • SAH组内endocan水平随时间进行性升高。
  • 48小时endocan水平与海马神经元变性评分呈探索性正相关(ρ=0.753,P=0.031,95%CI [0.112-0.948])。

临床怎么用

  • 目前仅为动物实验初步证据,尚不能用于临床决策或常规检测。
  • 可为后续开展更大规模临床前及临床验证研究提供方向。

局限性

  • 样本量小(每组n=8),为探索性实验研究。
  • 相关性分析为探索性,需更大规模研究验证。
  • 结论尚需在临床研究中进一步确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subarachnoid hemorrhage (SAH) is a severe neurological condition in which endothelial dysfunction contributes to early brain injury. However, reliable circulating biomarkers reflecting endothelial activation after SAH remain limited. Endocan, a proteoglycan secreted by activated endothelial cells, has emerged as a potential marker of endothelial dysfunction. This proof-of-concept study aimed to characterize the temporal profile of serum endocan in an experimental SAH model and to explore its association with neuronal injury. METHODS: Sixteen male Sprague-Dawley rats were randomly assigned to Sham (n = 8) or SAH (n = 8) groups. SAH was induced by cisterna magna injection of autologous blood. Serum samples were collected at baseline (0), 6, 24, and 48 hours. Endocan concentrations were measured using enzyme-linked immunosorbent assay. Hippocampal neuronal degeneration was assessed histopathologically. Statistical analyses included independent samples t-tests, repeated measures analysis of variance, and Spearman's correlation. RESULTS: Baseline endocan levels were comparable between groups (P = 0.655). Following SAH induction, serum endocan levels were significantly higher in the SAH group compared with the Sham group at 6 hours (P = 0.023), 24 hours (P < 0.001), and 48 hours (P < 0.001). Within the SAH group, endocan levels increased progressively over time. An exploratory positive correlation was observed between 48-hour endocan levels and hippocampal neuronal degeneration scores (ρ = 0.753, P = 0.031, 95% confidence interval [0.112-0.948]). CONCLUSIONS: In this exploratory experimental study, serum endocan increased over time after SAH and showed an association with neuronal injury severity. These preliminary findings suggest that endocan may reflect endothelial activation during early brain injury after SAH, warranting validation in larger preclinical and clinical studies.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Cetinkaya K, Özates MÖ, Kullukçu H, et al. Serum Endocan as a Potential Biomarker in Experimental Subarachnoid Hemorrhage: A Rodent Model Study. World Neurosurg. 2026. PMID: 41956409. doi:10.1016/j.wneu.2026.124976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。